Oskar Hansson
51 – 60 of 662
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2025
-
Mark
Plasma p-tau217 correlates strongly with cerebrospinal fluid Aβ42 and increases over a ten-year period in amyloid-positive, non-demented very old men
- Contribution to journal › Article
-
Mark
Complementary utility of plasma biomarkers and Aβ-PET for diagnosis, risk-stratification, and treatment monitoring in Alzheimer's disease
- Contribution to journal › Debate/Note/Editorial
-
Mark
Frequency and Clinical Outcomes Associated with Tau Positron Emission Tomography Positivity
- Contribution to journal › Article
-
Mark
Taurine Intake, Plasma Taurine Concentration, and Dementia Risk : Findings From the Malmö Diet and Cancer Study
- Contribution to journal › Article
-
Mark
Evidence-based standardized sample handling protocol for accurate blood-based Alzheimer's disease biomarker measurement : Results and consensus of the Global Biomarker Standardization Consortium
- Contribution to journal › Article
-
Mark
Alzheimer's disease diagnostic progression is associated with cerebrovascular disease and neuroinflammation in adults with Down syndrome
- Contribution to journal › Article
-
Mark
Alzheimer's disease outlook : controversies and future directions
- Contribution to journal › Scientific review
-
Mark
New landscape of the diagnosis of Alzheimer's disease
- Contribution to journal › Scientific review
-
Mark
Combining plasma p-tau217 and cross-cultural cognitive tests to identify Alzheimer's Disease in an ethnically diverse mixed memory clinic cohort
- Contribution to journal › Article
-
Mark
Personalised regional modelling predicts tau progression in the human brain
- Contribution to journal › Article
